Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Juhani Knuuti, William Wijns, Antti Saraste et al. · European Heart Journal · 2019 · 7.1K citations · Full text

Medicine, Cardiology, Clinical Sciences +16

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Massimo Piepoli, Arno W. Hoes, Stefan Agewall et al. · European Heart Journal · 2016 · 6.5K citations · Full text

Medicine, Cardiology, Internal Medicine +16

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Journal of Hepatology · 2016 · 4.8K citations

Medicine, Internal Medicine, Hepatology +9

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Eduardo Vilar‐Gómez, Yadina Martínez-Pérez, Luis Calzadilla Bertot et al. · Gastroenterology · 2015 · 2.4K citations · Full text

Medicine, Internal Medicine, Nutritional Sciences +11